Findings

What do systematic reviews say?

9 questions · 9 findings · 2 reviews · Developmental, Psychosocial and Learning Problems

No studies found 0 · 0%GRADE not reported 1 · 11.1%Very low 0 · 0%Low 2 · 22.2%Moderate 5 · 55.6%High 1 · 11.1%

Bayley Scale PDI within 30 days of commencement of therapy · children less than 3 years of age with iron deficiency anaemia

1 finding from 1 review

Bayley Scale MDI within 30 days of commencement of therapy · children less than 3 years of age with iron deficiency anaemia

1 finding from 1 review

Bayley Scale PDI more than 30 days of commencement of therapy · children less than 3 years of age with iron deficiency anaemia

1 finding from 1 review

Bayley Scale MDI more than 30 days of commencement of therapy · children less than 3 years of age with iron deficiency anaemia

1 finding from 1 review

Denver Developmental Screening Test more than 30 days of commencement of therapy · children less than 3 years of age with iron deficiency anaemia

1 finding from 1 review

Iron deficiency at end of therapy (total), as defined by trial authors · menstruating women (non‐pregnant women of reproductive age)

The intervention probably leads to lower iron deficiency at end of therapy (total), as defined by trial authors (moderate certainty).

1 finding from 1 review

Daily iron supplementation for improving anaemia, iron status and health in menstruating women 2016 · Cochrane Headline outcomes only
RR 0.62 [0.5, 0.76]
7 studies · 1088 participants
Moderate

Iron‐deficiency anaemia at end of therapy, as defined by trial authors · menstruating women (non‐pregnant women of reproductive age)

1 finding from 1 review

Daily iron supplementation for improving anaemia, iron status and health in menstruating women 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 55 participants
GRADE not reported

Anaemia at end of therapy (total), as defined by trial authors · menstruating women (non‐pregnant women of reproductive age)

The intervention probably leads to lower anaemia at end of therapy (total), as defined by trial authors (moderate certainty).

1 finding from 1 review

Daily iron supplementation for improving anaemia, iron status and health in menstruating women 2016 · Cochrane Headline outcomes only
RR 0.39 [0.25, 0.6]
10 studies · 3273 participants
Moderate

Haemoglobin at end of therapy (total), g/L · menstruating women (non‐pregnant women of reproductive age)

The intervention leads to higher haemoglobin at end of therapy (total), g/L (high certainty).

1 finding from 1 review

Daily iron supplementation for improving anaemia, iron status and health in menstruating women 2016 · Cochrane Headline outcomes only
MD 5.3 [4.14, 6.45]
51 studies · 6861 participants
High